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In commenting the results of our study on cysteinyl-
leukotrienes and histamine following metacholine
and AMP bronchial challenge Lee et al. are correct
in pointing out that our findings do not rule out
involvement of histamine in mediating the response
following adenosine monophosphate (APM) chal-
lenge. The failure to detect increases in histamine
following AMP challenge is probably due to the
sensitivity of the assay or factors that may reduce
the concentration of histamine in exhaled breath
condensate. We agree that the failure to identify
histamine in exhaled breath condensate certainly
does not exclude a role for histamine release from
mast cells activated by AMP.
Recently, Crummy and collegues investigated the
response to endobronchial AMP challenge in nor-
mal, atopic nonasthmatic and asthmatic subjects
and found that histamine, tryptase, protein, and
PGD2 concentrations all increased significantly
after endobronchial AMP challenge in healthy
subjects. However, the response in asthmatic and
atopic nonasthmatic subjects was variable with no
overall significant increase in mediator levels.1 Ouree front matter & 2004 Elsevier Ltd. All rights reserv
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nal article 10.1016/j.rmed.2004.09.004study is the first on post challenge histamine
detection in exhaled breath condensate, and we
agree with Dr. Lee and colleagues that further
studies, both with invasive and noninvasive techni-
ques, are necessary to understand which mediators
are involved in responses to bronchial challenge.Reference
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